06.16.26 -- Optimizing Fill-Finish For Complex Therapeutics

Integrated fill‑finish capabilities across multiple sterile formats improve workflow efficiency, enhance product consistency, and support planning for scaling and long‑term commercialization.

Animal‑free raw materials ensure reliable bioprocessing through stable molecular weight profiles, consistent mineral levels, and controlled manufacturing for dependable lot‑to‑lot performance.

Expanding capacity for late-phase clinical and large-scale commercial small molecule and biologic drugs, a new facility boosts sterile fill/finish capabilities.

A look at sterile injectable expansion highlighting investment, advanced fill‑finish technologies, and flexible manufacturing from development to commercial production.

Accelerate from development to commercialization with manufacturing solutions. Integrated digital systems and technical advocacy ensure regulatory excellence and batch release.

A pre-verified delivery platform eliminates redundant testing, simplifies regulatory submissions, and optimizes inventory management, allowing teams to focus on performance.

Unlike traditional CDMOs that stitch services together, Thermo Fisher Scientific connects our capabilities to streamline biologics development through Path to First-in-Human.

Bispecific antibodies combine two antigen-binding sites to enhance efficacy and safety. Their design requires a strategy, MOA-based evaluation, and screening for optimal therapeutic performance.

With a foundation built on operational excellence, cutting-edge technology, and strategic capacity expansion, we’re equipped to overcome the most demanding manufacturing challenges.

We offer industry-leading biologics development services to support global clients in all clinical phases and global regulatory arenas. Our comprehensive development services include both process and formulation development.

View how to implement USP <665> extractables testing, align with global E&L standards, and apply risk-based strategies to ensure regulatory compliance and patient safety.